[1] W. Stansel Boyd, C. F. Gilliland, O. Mississippi, and S. Moses, “How misinformation and distrust compound the specter of epidemics,” Olemiss.edu, 2020. [Online]. Accessible: https://egrove.olemiss.edu/cgi/viewcontent.cgi?article=2457&context=hon_thesis
[2] L. D. Racsa, C. S. Kraft, G. G. Olinger, and L. E. Hensley, “Viral hemorrhagic fever diagnostics,” Clin. Infect. Dis., vol. 62, no. 2, pp. 214–219, 2016.
[3] S. Delgado et al., “Chapare virus, a newly found arenavirus remoted from a deadly hemorrhagic fever case in Bolivia,” PLoS Pathog., vol. 4, no. 4, p. e1000047, 2008.
[4] CDC, “Remedy – Chapare hemorrhagic fever,” Facilities for Illness Management and Prevention, 04-Dec-2019. [Online]. Accessible: https://www.cdc.gov/vhf/chapare/therapy/index.html
[5] R. Loayza Mafayle et al., “Chapare hemorrhagic fever and virus detection in rodents in Bolivia in 2019,” N. Engl. J. Med., vol. 386, no. 24, pp. 2283–2294, 2022.
[6] H. Malhotra and A. Kumar, “Codon utilization signatures in Sabia and Chapare for host adaptation,” Bioinformation, vol. 17, no. 10, pp. 891–898, 2021.
[7] CDC, “Danger of publicity,” Facilities for Illness Management and Prevention, 05-Dec-2019. [Online]. Accessible: https://www.cdc.gov/vhf/chapare/publicity/index.html
[8] CDC, “Transmission – Chapare hemorrhagic fever,” Facilities for Illness Management and Prevention, 05-Dec-2019. [Online]. Accessible: https://www.cdc.gov/vhf/chapare/transmission/index.html
[9] R. Mangat and T. Louie, “Viral Hemorrhagic Fevers,” in StatPearls [Internet], StatPearls Publishing, 2022.
[10] CDC, “Indicators and signs – Chapare hemorrhagic fever,” Facilities for Illness Management and Prevention, 05-Dec-2019. [Online]. Accessible: https://www.cdc.gov/vhf/chapare/signs/index.html
[11] CDC, “Prognosis – Chapare hemorrhagic fever,” Facilities for Illness Prevention and Management, 05-Dec-2019. [Online]. Accessible: https://www.cdc.gov/vhf/chapare/analysis/index.html
[12] X. Carnec et al., “A vaccine platform towards arenaviruses based mostly on a recombinant hyperattenuated Mopeia virus expressing heterologous glycoproteins,” J. Virol., vol. 92, no. 12, 2018.
[13] CDC, “Prevention – Chapare hemorrhagic fever,” Facilities for Illness Management and Prevention, 05-Dec-2019. [Online]. Accessible: https://www.cdc.gov/vhf/chapare/prevention/index.html
[14] M. Zaghi, F. Banfi, E. Bellini, and A. Sessa, “Uncommon doesn’t imply nugatory: How uncommon illnesses have formed neurodevelopment analysis within the NGS period,” Biomolecules, vol. 11, no. 11, p. 1713, 2021.
